This is a funding opportunity (grant) for innovative screening approaches and therapies for screenable disorders in newborns. The grant is an R21 Clinical Trial Optional grant, and the CFDA number is 93.865.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.